Protective effect of triflusal against acute myocardial infarction in patients with unstable angina: results of a Spanish multicenter trial. Grupo de Estudio del Triflusal en la Angina Inestable.

@article{Plaza1993ProtectiveEO,
  title={Protective effect of triflusal against acute myocardial infarction in patients with unstable angina: results of a Spanish multicenter trial. Grupo de Estudio del Triflusal en la Angina Inestable.},
  author={Luis Plaza and L. L{\'o}pez-bescos and Lu{\'i}s Mart{\'i}n-Jadraque and Eduardo Alegr{\'i}a and Jos{\'e} Mar{\'i}a Cruz-Fern{\'a}ndez and Julio Velasco and Juan Antonio Ruip{\'e}rez and F{\'e}lix Malpartida and {\'A}ngel Artal and Adolfo Cabad{\'e}s},
  journal={Cardiology},
  year={1993},
  volume={82 6},
  pages={388-98}
}
A multicenter, double-blind, placebo-controlled study was carried out to evaluate the effect of a new antiplatelet agent, triflusal (2-acetoxy-4-trifluoromethyl benzoic acid), in the prevention of nonfatal myocardial infarction and cardiac or vascular death (principal end-points) in patients with unstable angina. 281 patients were randomly assigned to… CONTINUE READING